A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study

Elaine S. Rogers*, Roderick D. MacLeod, Joanna Stewart, Stephen P. Bird, Justin W L Keogh

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

23 Citations (Scopus)
19 Downloads (Pure)

Fingerprint Dive into the research topics of 'A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study'. Together they form a unique fingerprint.

Medicine & Life Sciences